NASDAQ:ZCMD Zhongchao (ZCMD) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free ZCMD Stock Alerts $1.69 +0.20 (+13.42%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$1.42▼$1.7850-Day Range$1.26▼$4.5752-Week Range$1.20▼$14.00Volume673,551 shsAverage Volume2.38 million shsMarket Capitalization$3.24 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Get Zhongchao alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Zhongchao Stock (NASDAQ:ZCMD)Zhongchao Inc. provides healthcare information, education, and training services in the People's Republic of China. The company offers online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. It also provides customized medical courses and medical training services; and patient management services through online platform under the Zhongxun brand. The company operates through its mdmooc.org online platform under the MDMOOC brand; and Sunshine Health Forums, a Wechat subscription account and mobile app. It serves enterprises, non-for-profit organizations, and medical journals, as well as healthcare professionals, nurses, doctors, and other healthcare workers. The company was founded in 2012 and is headquartered in Shanghai, China.Read More ZCMD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ZCMD Stock News HeadlinesApril 26, 2024 | americanbankingnews.comShort Interest in Zhongchao Inc. (NASDAQ:ZCMD) Grows By 386.4%April 19, 2024 | investorplace.comWhy Is Zhongchao (ZCMD) Stock Up 103% Today?April 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 16, 2024 | morningstar.comZHONGCHAO Inc Ordinary Shares - Class AApril 5, 2024 | msn.comAltice USA, Genfit, Brooge Energy among premarket losers' packApril 4, 2024 | investorplace.comWhy Is Zhongchao (ZCMD) Stock Up 40% Today?March 12, 2024 | prnewswire.comZhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of MedicationsMarch 5, 2024 | msn.comWhy Paymentus Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving PremarketApril 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.March 5, 2024 | investorplace.comWhy Is Zhongchao (ZCMD) Stock Up 15% Today?February 27, 2024 | prnewswire.comZhongchao Inc. Announces 1-for-10 Share ConsolidationDecember 28, 2023 | finance.yahoo.comZhongchao First Half 2023 Earnings: US$0.18 loss per share (vs US$0.004 profit in 1H 2022)December 11, 2023 | finance.yahoo.comZhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer TreatmentsOctober 23, 2023 | finance.yahoo.comZhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness DaySeptember 25, 2023 | finance.yahoo.comZhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer PatientsAugust 24, 2023 | finance.yahoo.comZhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease ManagementJuly 11, 2023 | finance.yahoo.comZhongchao Inc. Partners with Ximalaya to Launch the First Audio Course Series for Cancer EducationJune 12, 2023 | finance.yahoo.comZhongchao Inc. Launch Digital Online Education Platform for Common Diseases Clinical Diagnosis and TreatmentMay 12, 2023 | finance.yahoo.comZhongchao Inc. Announces Strategic Cooperation with XimalayaMay 8, 2023 | finance.yahoo.comZhongchao Inc. Announces Naiditawei® Enrolled as a Listed Online Procurement Drug in Ten Provinces(Districts, Cities) in ChinaApril 24, 2023 | finance.yahoo.comZhongchao Inc. Partners with a Public Health Foundation to Safeguard Cancer Patients' HealthMarch 30, 2023 | finance.yahoo.comZhongchao Inc. Announces Launch of Health Education Intelligent Content Production PlatformMarch 13, 2023 | finance.yahoo.comZhongchao Inc. Releases Survey Results for Bone Marrow Cancer Patient Services with More than 80% Patients Indicating Full SatisfactionFebruary 24, 2023 | ca.finance.yahoo.comZhongchao Inc. (ZCMD) Stock Historical Prices & Data - Yahoo FinanceFebruary 23, 2023 | finance.yahoo.comZhongchao Inc. Renews Partnership with Johnson & Johnson (China)February 13, 2023 | finance.yahoo.comZhongchao Inc. Announces the Application of ChatGPT for Its MDMOOC Platform to Assist Physicians in Clinic Decision Making and Improve Treatment EfficiencyFebruary 9, 2023 | msn.com11 Consumer Discretionary Stocks Moving In Thursday's Intraday SessionSee More Headlines Receive ZCMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Zhongchao and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/27/2024Next Earnings (Estimated)5/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Educational services Sub-IndustryN/A Current SymbolNASDAQ:ZCMD CUSIPN/A CIK1785566 Webwww.mdmooc.org Phone02132205987Fax86-021-3220-5987Employees116Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$14.15 million Price / Sales0.23 Cash FlowN/A Price / Cash FlowN/A Book Value$18.26 per share Price / Book0.09Miscellaneous Outstanding Shares1,920,000Free Float1,369,000Market Cap$3.24 million OptionableNot Optionable Beta0.31 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Weiguang Yang (Age 42)Founder, Chairman, President & CEO Comp: $157.5kMs. Pei Xu (Age 42)CFO, Secretary & Director Comp: $59.72kMs. Shuang Wu (Age 41)Chief Operating Officer Comp: $57.24kMr. Baoqian Tian (Age 40)Chief Sales Officer Comp: $112.28kMr. Xuejun Chen (Age 46)Chief Medical Officer Comp: $112.62kKey CompetitorsInnovative EyewearNASDAQ:LUCYRevelation BiosciencesNASDAQ:REVBPhio PharmaceuticalsNASDAQ:PHIOKiromic BioPharmaNASDAQ:KRBPAtrecaNASDAQ:BCELView All Competitors ZCMD Stock Analysis - Frequently Asked Questions How have ZCMD shares performed in 2024? Zhongchao's stock was trading at $3.5110 on January 1st, 2024. Since then, ZCMD shares have decreased by 51.9% and is now trading at $1.69. View the best growth stocks for 2024 here. Are investors shorting Zhongchao? Zhongchao saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 39,400 shares, an increase of 386.4% from the March 31st total of 8,100 shares. Based on an average daily volume of 921,300 shares, the short-interest ratio is presently 0.0 days. Approximately 2.7% of the company's stock are short sold. View Zhongchao's Short Interest. When is Zhongchao's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our ZCMD earnings forecast. When did Zhongchao's stock split? Zhongchao's stock reverse split before market open on Thursday, February 29th 2024. The 1-10 reverse split was announced on Thursday, February 29th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, February 29th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What other stocks do shareholders of Zhongchao own? Based on aggregate information from My MarketBeat watchlists, some companies that other Zhongchao investors own include Acasti Pharma (ACST), Ayala Pharmaceuticals (ADXS), Aehr Test Systems (AEHR), FuelCell Energy (FCEL), Globus Maritime (GLBS), IntelGenx Technologies (IGXT), Rave Restaurant Group (RAVE), Sino-Global Shipping America (SINO) and VEON (VEON). When did Zhongchao IPO? Zhongchao (ZCMD) raised $15 million in an initial public offering (IPO) on the week of February 24th 2020. The company issued 3,500,000 shares at $4.00-$4.50 per share. Network 1 Financial Securities acted as the underwriter for the IPO. How do I buy shares of Zhongchao? Shares of ZCMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ZCMD) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zhongchao Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
